0
Curis, Inc.
- 51-200 Employees
- Based in Lexington, Massachusetts
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers. The company develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase I clinical trials for advanced lymphomas and multiple myeloma; and HER 2-/ ER+ or PR+ breast cancer, and NUT…More
Curis, Inc.
Most Recent Annual Report
Curis, Inc. does not currently have any hardcopy reports on ²©¾ÅÓéÀÖÍø. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
